Why restricted mean survival time methods are especially useful for non-inferiority trials.

MLA

Quartagno, Matteo, et al. “Why Restricted Mean Survival Time Methods Are Especially Useful for Non-Inferiority Trials.” Clinical Trials (London, England), vol. 18, no. 6, Dec. 2021, pp. 743–45. EBSCOhost, https://doi.org/10.1177/17407745211045124.

APA

Quartagno, M., Morris, T. P., & White, I. R. (2021). Why restricted mean survival time methods are especially useful for non-inferiority trials. Clinical Trials (London, England), 18(6), 743–745. https://doi.org/10.1177/17407745211045124

Chicago

Quartagno, Matteo, Tim P Morris, and Ian R White. 2021. “Why Restricted Mean Survival Time Methods Are Especially Useful for Non-Inferiority Trials.” Clinical Trials (London, England) 18 (6): 743–45. doi:10.1177/17407745211045124.